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A B S T R A C T
Recent studies indicate that oxidative stress caused by Helicobacter pylori and insufficient host antioxidant defense
could play important role in pathogenesis of gastrointestinal ulcerations. By specific monoclonal antibodies we have de-
tected weak presence of the major lipid peroxidation bioactive marker 4-hydroxynonenal (HNE) in healthy human gas-
tric mucosa, which strongly increased in case of H. pylori-associated peptic ulcer. Considering physiological presence of
HNE on one hand, and high prevalence of H. pylori associated disorders on the other, evaluation of oxidative stress after
treatment is important. Therefore, in current study immunohistochemical accumulation and distribution of HNE-pro-
tein adducts in gastric mucosa was evaluated with 21 patients having H. pylori-associated duodenal peptic ulcer (DPU)
before and one month after eradication of H. pylori. Although dramatic decrease in histological manifestations of in-
flammation was demonstrated after eradication of H. pylori, initially high immunopositivity for the HNE-protein ad-
ducts remained elevated in antrum and even increased in stomach corpus. The observed accumulation and redistribu-
tion to higher grades of HNE-immunopositivity in nuclei of glandular cells in gastric corpus indicate augmentation of
oxidative stress after treatment and open possibilities for adjuvant antioxidant treatments to protect gastric mucosa from
progressive oxidative stress after eradication of H. pylori infection.
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Introduction
Eradication of Helicobacter pylori became the stan-
dard treatment strategy for duodenal peptic ulcer (DPU)
and other disorders associated with this microorganism
since 1996. Moreover, such approach has been demon-
strated to decrease the incidence of gastric adenocar-
cinoma. It is known, that H. pylori causes chemotaxis of
neutrophiles and macrophages, their activation with ex-
cessive release of reactive oxygen species (ROS), mainly
superoxide anion leading to development of inflamma-
tion. Activation of free radical reactions and lipid pero-
xidation triggers a number of metabolic cascades aimed
to increase an antioxidant defense. Oxidative stress (OS)
would develop as a result of excessive oxidative destruc-
tion of macromolecules (lipids, proteins, and nucleic acids)
and consecutive accumulation of their oxidized products
in cells. Its substantial role in initiation and progression
of H. pylori – associated diseases is well known. Accumu-
lation of products of lipid peroxidation and oxidative
modification of proteins and nucleic acids in gastric mu-
cosa of H. pylori infected subjects was documented. How-
ever, the depth of OS and clinical manifestations, which
can vary from asymptomatic bearing to DPU and even
malignancy, would depend upon the balance between the
strength of pathogenic impact (H. pylori) and power of
defensive mechanisms of the affected mucosa and entire
body.
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4-hydroxy-2,3-trans-nonenal (HNE) is well known se-
condary product of peroxidation of w-6 polyunsaturated
fatty acids and exhibits concentration-depended action.
Its excessive accumulation has been associated with OS
while in physiologic concentrations HNE has been found
to be an important signaling molecule regulating pro-
cesses of differentiation, proliferation, apoptosis, inflam-
mation, and energy metabolism. Our recent findings
showed little amount of HNE in normal human gastric
mucosa and excessive HNE-histidine conjugates accu-
mulation in H. pylori positive DPU patients. Therefore,
the aim of our study was to evaluate if eradication of H.
pylori would result in attenuation of the HNE-presence
in the gastric mucosa. That could be helpful to determine
if standard eradication therapy is sufficient for recovery
of mucosa with DPU patients including elimination OS
and would provide insights into the role of the macro-
organism in the ulcerogenesis.
Materials and Methods
Subjects
Twenty nine H. pylori positive patients aged 18–44
with endoscopically proved active DPU were enrolled
into the study (mean age 32.1±1.7, 18 males and 11 fe-
males). 20 healthy volunteers (mean age 29.7±1.4, 13
males and seven females) without any gastrointestinal
complaints and other registered health problems were
used as a control group. Out of these patients eight were
positive and 12 were negative for H. pylori presence. All
H. pylori positive DPU patients were prescribed triple
therapy (Lansoprazole 30 mg, Amoxicillin 1000 mg, and
Clarithromycin 500 mg twice per day for seven days). Af-
ter four to five weeks from the completion of the anti-
microbial treatment patients underwent control endo-
scopic examination. The design of the study was approved
by local Ethics Committee at Lviv National Medical Uni-
versity and informed consent was obtained from all pa-
tients and healthy volunteers.
Histology and assessment of H. pylori infection
Two biopsy specimens were obtained endoscopically
from antrum and two from corpus of the stomach in all
cases for histological examination. Namely, it is known
that H. pylori are living in gastric mucosa predominantly
in antrum and less likely in corpus of the stomach. Be-
cause of that, the specimens used for analytical and diag-
nostic purposes are taken from antrum and corpus. In
duodenum this microorganism is rarely observed, while
the risk of complications (perforation, haemorrhage) is
much higher. Therefore, biopsies of duodenum are con-
sidered as relative risk and are not performed without
good medical indices. Biopsy specimens were immedi-
ately fixed in buffered 10.0% formalin, then dehydrated
in ethanol and embedded in paraffin, cut into 5-mm thick
sections and examined with haematoxylin-eosin and
modified Giemsa staining. Histologically, H. pylori infec-
tion was considered as negative if H. pylori were absent
in all biopsies obtained from one patient and positive if it
was found in at least one sample. Inflammation, contam-
ination of H. pylori, glandular atrophy and intestinal
metaplasia were classified qualitatively as negative (0) or
positive (1); and semi-quantitatively into four grades ac-
cording to updated Sydney System as follows: 0, none; 1,
mild; 2, moderate and 3, severe.
Determination of HNE-histidine conjugates
Paraffin blocks obtained only from patients with suc-
cessful eradication of H. pylori (n=21) before and after
treatment were further used for immunohistochemical
staining: one slice of each specimen was cut into 5-mm
thin sections, mounted on the slide coated with 3-amino-
propyl-triethoxy silane, deparaffinated in xylene and re-
hydrated trough a series of ethanol. Immunohistoche-
mistry for HNE-modified proteins was carried out using
monoclonal antibodies obtained from culture medium of
the clone 'HNE 1g4', produced by a fusion of Sp2-Ag8
myeloma cells with B-cells of a BALB-c mouse immu-
nized with HNE-modified keyhole limpet hemocyanine.
The antibody is specific for the HNE-histidine epitope in
HNE-protein (peptide) conjugates and gives only 5%
cross-reactivity with HNE-lysine and 4% with HNE-
-cysteine.
Immunohistochemistry was done in a three step pro-
cedure as described before using LSAB kit (DAKO, Den-
mark) where the first step was incubation with anti-
-HNE monoclonal antibodies (dilution 1:10) during 2 h
in humid chambers at room temperature. The second
step was incubation with biotinylated secondary goat
anti-mouse and anti-rabbit immunoglobulins (AB2) dur-
ing 30 min. The third step was incubation with strep-
tavidin peroxidase during 30 min. Finally, the reaction
was visualized by a DAB (3.3-diaminobenzidine tetra-
hydrochloride in organic solvent) after 10 min. Negative
control was done on one histological slice of the same tis-
sue, without application of HNE-histidine specific mono-
clonal antibodies. Intensity and distribution of the HNE-
-immunostaining in the gastric mucosa from antrum and
corpus of the stomach were evaluated semi-quantita-
tively. The absence of immunopositivity in cytoplasm and
nuclei of glandular epithelial cell was marked with (0),
while with (1) we marked weak immunopositivity in less
than 25% of the cells, with (2) medium immunopositivity
in 25–50% of cells and finally with (3) strong immuno-
positivity in more than 50% of cells. In superficial and
foveolar epithelium, as well as in lamina propria of gas-
tric mucosa, we distinguished only positive (1) and nega-
tive (0) immunostaining. All immunohistochemical anal-
yses were done by a pathologist experienced in the HNE
immunohistochemistry without prior knowledge of the
study group design.
Statistical analysis
The prevalence of H. pylori infection, inflammation,
glandular atrophy and intestinal metaplasia, as well as
incidence of HNE in gastric tissues, was evaluated by
2-test after classifying the marker as positive or nega-
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tive. Possible difference in H. pylori contamination and
intensity of HNE staining were done by Mann-Whitney
U-test, using numerical description of positivity corre-
sponding to respective standard grading of positivity as
described above. Calculations were carried out using sta-
tistical software SPSS 9.0.
Results
Manifestations of inflammation in gastric mucosa,
predominantly macrophagic and less frequently neutro-
philic infiltration, were found much more commonly in
DPU patients before H. pylori eradication than in control
group (Table 1). H. pylori were found in four patients af-
ter treatment with acceptable eradication rate 81% (17
cases of 21). Eradication of H. pylori was associated with
dramatic decrease in inflammatory markers in gastric
mucosa of DPU patients: neutrophilic infiltration was
not observed (p<0.05) while macrophagic infiltration re-
mained in only two patients (p<0.05).
Immunohistochemical analysis revealed the presence
of the HNE-histidine conjugates in gastric mucosa of
DPU patients, as well as in control group (Table 2). Be-
fore eradication of H. pylori in DPU patients we found
accumulation of HNE-histidine adducts in nuclei of glan-
dular epithelium in antrum of nine patients (42.9%) and
in corpus of the stomach of the four patients (19.0%) in
contrast to control group where HNE-positivity was not
found in the epithelial nuclei at all (Table 2).
After eradication of H. pylori the HNE presence sig-
nificantly decreased only in superficial epithelium
(p<0.05) while in foveolar epithelium of gastric corpus it
even increased (p<0.05). In other parts of stomach the
accumulation of the HNE-histidine adducts did not cha-
nge obviously while it even increased in nuclei of glandu-
lar cells in corpus (Table 2).
Further semiquantitative analysis showed different
effects of H. pylori eradication on the accumulation HNE-
-protein adducts in antrum and in corpus of the stomach
(Table 3).
In glandular epithelium of antrum before treatment
we observed HNE-positivity of the epithelial cytoplasm
in all 21 patients out of which four cases (19.1%) were of
first grade, three (14.3%) were of second and 14 (66.7%)
of third grade of the HNE-immunopositivity. The pres-
ence of HNE in the epithelial nuclei was observed in 9/21
(42.9%) patients, out of which six cases (28.6%) were of
second and three (14.3%) were of the third grade of
positivity. After H. pylori eradication no significant chan-
ge of the HNE presence was noted according to the inci-
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TABLE 1
PREVALENCE OF H. PYLORI INFECTION AND RESULTS OF HISTOLOGICAL EXAMINATION OF GASTRIC MUCOSA OF DUODENAL
PEPTIC ULCER PATIENTS
Parameters
Healthy control (n=20) DPU patients before eradication (n=21) DPU patients after eradication (n=21)
Antrum Corpus Antrum Corpus Antrum Corpus
H. pylori 8 (40.0) 7 (35.0) 21 (100.0)* 19 (90.5)* 2 (9.5)*# 2 (9.5)*#
Neutrophils 2 (10.0) 2 (10.0) 5 (23.8) 3 (14.3) 0 (0.0) # 0 (0.0)
Monocytes 8 (40.0) 7 (35.0) 21 (100.0)* 21 (100.0)* 2 (9.5)* 2 (9.5)*
Atrophy 0 (0.0) 0 (0.0) 2 (9.5) 3 (14.3) 1 (4.8) 2 (9.5)
Metaplasia 0 (0.0) 0 (0.0) 1 (4.8) 0 (0.0) 1 (4.8) 0 (0.0)
Dysplasia 0 (0.0) 0 (0.0) 1 (4.8) 0 (0.0) 0 (0.0) 0 (0.0)
Lymphoid folicules 2 (10.0) 2 (10.0) 7 (33.3) 5 (23.8) 1 (4.8) # 0 (0.0) #
§the relative incidence values (%) are given in brackets; *the difference comparing to control group by c2 – test significant at ð<0.05;
#the difference before and after treatment by c2 – test significant at ð<0.05.
TABLE 2
4-HYDROXYNONENAL-IMMUNOHISTOCHEMISTRY OF GASTRIC MUCOSA IN HEALTHY SUBJECTS AND IN PATIENTS
WITH DUODENAL PEPTIC ULCER (DPU)
Parameters
Healthy control (n=20)
DPU patients before eradication
(n=21)
DPU patients after eradication
(n=21)
Antrum Corpus Antrum Corpus Antrum Corpus
Superficial epithelium 2 (10.0)§ 0 (0.0) 7 (33.3) 15 (71.4)* 8 (38.1)* 6 (28.6)*#
Foveolar epithelium 1 (5.0) 0 (0.0) 10 (47.6)* 10 (47.6)* 8 (38.1)* 17 (81.0)*#
Lamina propria 7 (35.0) 8 (40.0) 16 (76.2)* 16 (76.2)* 17 (81.0)* 20 (95.2)*
Cytoplasm of glandular cells 20 (100.0) 19 (95.0) 21 (100.0) 21 (100.0) 19 (90.5) 21 (100.0)
Nuclei of glandular cells 0 (0.0) 0 (0.0) 9 (42.9)* 4 (19.0)* 8 (38.1)* 9 (42.9)*
§the relative incidence values (%) are given in brackets; *the difference comparing to control group by c2 – test significant at ð<0.05;
#the difference before and after treatment by c2 – test significant at ð<0.05.
dence of the immunopositive subjects when antrum mu-
cosa was analysed.
Quite different findings were noted in corpus of stom-
ach (Table 3). Before H. pylori eradication we observed
HNE-positivity in the cytoplasm of glandular cells in ev-
ery patients being mild in one patient (4.8%), moderate
in 14 (66.7%) and very prominent in six volunteers
(28.6%). Epithelial nuclei were HNE-positive in only four
(19.0%) subjects expressing mild to moderate HNE pres-
ence. However, one month after H. pylori eradication sig-
nificant further increase in HNE-protein adducts was
observed (p<0.001 in cytoplasm and p=0.037 in nuclei).
Redistribution of HNE-histidine adducts resulted in hi-
gher grades of immunopositivity both in cytoplasm and
in nuclei of these patients (Table 3).
Discussion
Major risk factors of peptic ulcer include H. pylori,
emotional stress, tobacco and alcohol abuse, gastric hy-
peracidity, and heredity, which facilitates imbalance be-
tween factors of aggression and defense. In this process
the leading role belongs to cellular hypoxia accompanied
by microcirculatory dysfunction, OS, and inflammation
with subsequent reduction of protective mechanisms in
gastric and duodenal mucosa. The derangements of cyto-
-protection appear mainly due to decline in intensity, effi-
ciency and coupling of redox reactions in cells. The latter
are needed for utilization of oxidative destruction prod-
ucts and maintenance of pO2 by oxygen generation in
radical reactions. Recently, essential trigger role of ROS
in various signaling pathways, activation of mitochon-
drial function, and consequential increase in energy and
adaptive potential is widely discussed as vital property of
the living system. In this regard, excessive accumulation
of oxidatively modified products appears to be due to the
high rate of their production on the one hand, while on
the other it can reflect decrease in their elimination. In
other words, metabolically active tissues produce signifi-
cant amounts of ROS and their derivatives, but detoxifi-
cation systems efficiently eliminate them, thus keeping
them at physiological levels. However, decreased rate of
electron transfer in respiratory chain with consequent
increased leak of and extreme production of superoxide,
which cannot be compensated, causes free radical de-
struction of cell structures, failure of mitochondrial func-
tion, decline of ATP production, fall of membrane poten-
tial, lack of detoxification activity and accumulation of
these waste products.
HNE is ubiquitous product of lipid peroxidation and
exerts concentration-dependent action on regulation of
inflammation (limitation of NF-kB and enhancement
p38 pathways activities), proliferation and apoptosis (ac-
tivation of JNK and inhibition of p53 pathways respec-
tively), reinforcement of antioxidant defense and detoxi-
fication through Nrf2/ARE cascades induction, and
energy metabolism by stimulation of PPAR nuclear re-
ceptors. Thus, HNE possesses dual properties in cell me-
tabolism, and in physiological concentrations it is impor-
tant regulatory molecule, while in high concentrations
serves as valuable marker of OS.
In accordance with our previous findings the results
presented in this study indicate excessive accumulation
of HNE-histidine adducts in gastric mucosa in foveolar
epithelium, lamina propria, and especially in nuclei of
glandular cells with PUD patients comparing to healthy
volunteers. Our current study revealed that eradication
of H. pylori dramatically reduces inflammatory cells in-
filtration of mucosa and improves clinical symptoms as
assessed one month after treatment completion. It can
be assumed that decrease of OS manifestations could be
expected due to pathogen removal. However, the only sig-
nificant decrease in HNE accumulation after treatment
was observed in superficial epithelium of the stomach
corpus. This can be attributed to removal of H. pylori im-
pact on superficial epithelium due to eradication of mi-
croorganism, and, probably, only superficial gastric epi-
thelium is significantly suffering from oxidative damage
induced by this microb. At the same time accumulation
of HNE-histidine adducts in other locations did not de-
A. Cherkas et al.: 4-Hydroxynonenal Accumulation after H. Pylori Eradication, Coll. Antropol. 33 (2009) 3: 815–821
818
TABLE 3
SUBCELLULAR 4-HYDROXYNONENAL-IMMUNOHISTOCHEMISTRY OF GASTRIC MUCOSA IN DUODENAL PEPTIC
ULCER PATIENTS BEFORE AND ONE MONTH AFTER ERADICATION TREATMENT
Grade of positivity*
Antrum (n=21) Corpus (n=21)
Before eradication After eradication Before eradication After eradication
Glandular cytoplasm 0 0 (0.0)§ 2 (9.5) 0 (0.0) 0 (0.0)
1 4 (19.1) 0 (0.0) 1 (4.76) 0 (0.0)
2 3 (14.3) 6 (28.6) 14 (66.7) 2 (9.5)
3 14 (66.7) 13 (61.9) 6 (28.6) 19 (90.5)
Glandular nuclei 0 12 (57.1) 13 (61.9) 17 (81.0) 12 (57.1)
1 0 (0.0) 1 (4.8) 2 (9.5) 0 (0.0)
2 6 (28.6) 5 (23.8) 2 (9.5) 3 (14.3)
3 3 (14.3) 2 (9.5) 0 (0.0) 6 (28.6)
*Semiquantitative staging as described in Material and methods; § relative incidence values are given in brackets (%)
crease markedly and even increased in foveolar epithelium,
lamina propria and glandular nuclei of gastric corpus.
Further semiquantitative analysis in glandular cells
allowed specifying intracellular accumulation of HNE-
-histidine adducts. Significant redistribution of HNE ad-
ducts on account of more pronounced immunopositivity
(predominantly grade 3) after treatment, especially in
corpus of the stomach was observed. Hence, our results
indicate persistence and even progression of OS and lipid
peroxidation in gastric mucosa one month after H. pylori
eradication.
The current literature data do not allow conclusions
in respect to the OS manifestations after H. pylori eradi-
cation in human mucosa. Most studies report successful
elimination or decrease of products of oxidative degrada-
tion after H. pylori eradication. However some studies
indicate persistence of OS manifestations after H. pylori
eradication with many patients. These data together
with our findings support clinical observation of recur-
rence of DPU, persistence of dyspepsia and even high risk
of gastric adenocarcinoma development with some pa-
tients despite successful H. pylori eradication. Severe ac-
cumulation of HNE-protein adducts after eradication
could explain recurrence of clinical manifestations due to
chemoattractive properties of this aldehyde, which sup-
ports migration of macrophages and neutrophiles to gas-
tric mucosa, maintaining local inflammion. Thus, exces-
sive HNE accumulation in gastric mucosa could depend
not only on H. pylori infection but also on host factors,
e.g. individual resistance to oxidative challenge. This
possibility is also supported by commonly found small ac-
cumulation of HNE in all H. pylori positive healthy vol-
unteers. In other words, the excessive accumulation of
HNE-protein adducts appears as a result of decreased re-
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Fig. 2. Immunohistochemical appearance of 4-hydroxynonenal (HNE) in gastric mucosa of H. pylori-positive duodenal peptic ulcer pa-
tients: a) accumulation of HNE-histidine conjugates was found in cytoplasm and in some nuclei of glandular cells before treatment,
magnification 400´; b) HNE-immunopositivity increased, especially prominent accumulation of HNE in nuclei of glandular cells, 4-5
weeks after H. pylori eradication, magnification 400´.
Fig. 1. Immunohistochemical appearance of 4-hydroxynonenal (HNE) in gastric mucosa of healthy volunteers: a) mild accumulation of
HNE-histidine conjugates was found in cytoplasm and no HNE-positivity in nuclei of glandular cells in H. pylori-negative healthy subject,
magnification 200´; b) weak HNE-immunopositivity of gastric mucosa of H. pylori-positive asymptomatic subject, magnification 200´.
sistance to OS, while normal or high resistance is associ-
ated with its mild accumulation.
Although these aspects of eradication therapy require
further studies, they point to the importance of ulcero-
genic mechanisms, other than H. pylori infection. Our
study also signifies the importance of administration of
antioxidant treatment aimed to reduce of OS manifesta-
tions in complex DPU management (such as plant oils
containing polyunsaturated fatty acids, caloric restric-
tion, etc.) with subsequent induction of endogenous anti-
oxidant mechanisms.
Conclusions
Successful H. pylori eradication dramatically reduced
inflammatory cells infiltration in gastric mucosa, as as-
sessed in four to five weeks after treatment. However, it
did not decrease the presence of HNE-protein adducts in
gastric mucosa. H. pylori eradication even caused in-
crease in HNE accumulation in cytoplasm and especially
in nuclei of glandular cells in gastric corpus. Taken to-
gether, these findings indicate persistence of oxidative
stress after elimination of pathogenic microorganism
with DPU patients and necessity of adjuvant treatment
options aimed at protection from oxidative challenge.
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POVE]ANO NAKUPLJANJE 4-HIDROKSINONENAL-PROTEINSKIH KONJUGATA U @ELU^ANOJ
SLUZNICI ZAOSTAJE NAKON IZLJE^ENJA HELICOBACTER PYLORI
S A @ E T A K
Dosada{nja istra`ivanja pokazala su da bi oksidacijski stres uzrokovan bakterijom Helicobacter pylori, zajedno sa
smanjenom antioksidacijskom za{titom doma}ina, mogao igrati zna~ajnu ulogu u patogenezi `elu~anog ulkusa. U prija-
{njem radu dokazali smo izvornim monoklonskim protutijelima slabi pozitivitet 4-hidroksinonenala (HNE), glavnog
bioaktivnog biljega lipidne peroksidacije, u fiziolo{kim uvjetima u zdravoj ljudskoj `elu~anoj sluznici. Pozitivitet HNEa
poja~avao se u slu~aju infekcije s H. pylori kao i kod pepti~nog ulcua. Obzirom na fiziolo{ku prisutnost HNEa s jedne
strane i visoke u~estalosti bolesti vezane uz H. pylori s druge strane, procjena oksidacijskog stresa nakon tretmana
mogla bi biti va`an progosti~ki parametar. U ovom radu pra}ena je imunohistokemijska distribucija HNE-proteinskih
konjugata u `elu~anoj sluznici kod 21 pacijenta sa ulcusom dvanaesnika (DPU) izazvanim H. pylori prije lije~enja i
mjesec dana poslije lije~enja. Uo~eno pove}anje i preraspodjela HNE-pozitiviteta u jezgri `ljezdanih stanica u tijelu
`eluca ukazuju na pove}anje oksidacijskog stresa nakon tretmana te time pru`a mogu}nost adjuvantnog antioksida-
cijskog tretmana za za{titu sluznice `eluca od razvoja oksidacijskog stresa i lipidne peroksidacije u i nakon infekcije s H.
pylori. Nakon izlije~enja H. pylori, histolo{ki pokazatelji upale su drasti~no sni`eni, no koli~ina HNE- proteinskih
konjugata je i dalje povi{ena u antrumu, te dodatno povi{ena u tijelu `eluca.
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